Literature DB >> 12680802

Hypertrophic scars and keloids: etiology and management.

Tina S Alster1, Elizabeth L Tanzi.   

Abstract

Keloid and hypertrophic scars have affected patients and frustrated physicians for centuries. Keloid and hypertrophic scars result from excessive collagen deposition, the cause of which remains elusive. Clinically, these scars can be disfiguring functionally, aesthetically, or both. A thorough understanding of the pathophysiology and clinical nature of the scar can help define the most appropriate treatment strategy. Although many articles have been published on the management of hypertrophic and keloid scars, there is no universally accepted treatment protocol. Prevention of keloid and hypertrophic scars remains the best strategy; therefore, those patients with a predisposition to develop excessive scar formation should avoid nonessential surgery. Once a scar is present, there are many treatments from which to choose. Hypertrophic scars and keloids have been shown to respond to radiation, pressure therapy, cryotherapy, intralesional injections of corticosteroid, interferon and fluorouracil, topical silicone or other dressings, and pulsed-dye laser treatment. Simple surgical excision is usually followed by recurrence unless adjunct therapies are employed. Biologic agents that are directed towards the aberrant collagen proliferation that characterizes keloid and hypertrophic scars might be an important addition to the current armamentarium of modalities in the near future.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12680802     DOI: 10.2165/00128071-200304040-00003

Source DB:  PubMed          Journal:  Am J Clin Dermatol        ISSN: 1175-0561            Impact factor:   7.403


  60 in total

Review 1.  [The treatment of keloids].

Authors:  I Hackert; R Aschoff; G Sebastian
Journal:  Hautarzt       Date:  2003-10       Impact factor: 0.751

2.  Keloids: pathogenesis, clinical features, and management.

Authors:  Chuma J Chike-Obi; Patrick D Cole; Anthony E Brissett
Journal:  Semin Plast Surg       Date:  2009-08       Impact factor: 2.314

3.  Mechanism of benign biliary stricture: a morphological and immunohistochemical study.

Authors:  Zhi-Min Geng; Ying-Min Yao; Qing-Guang Liu; Xin-Jie Niu; Xiao-Gong Liu
Journal:  World J Gastroenterol       Date:  2005-01-14       Impact factor: 5.742

4.  Abnormal scar identification with spherical-nucleic-acid technology.

Authors:  David C Yeo; Christian Wiraja; Amy S Paller; Chad A Mirkin; Chenjie Xu
Journal:  Nat Biomed Eng       Date:  2018-04-13       Impact factor: 25.671

Review 5.  A primary care perspective on keloids.

Authors:  Steven Davidson; Nasir Aziz; Rashid M Rashid; Amor Khachemoune
Journal:  Medscape J Med       Date:  2009-01-20

6.  Management of pediatric penile keloid.

Authors:  Michael Yong; Kourosh Afshar; Andrew Macneily; Jugpal S Arneja
Journal:  Can Urol Assoc J       Date:  2013 Sep-Oct       Impact factor: 1.862

7.  Surgical treatment of burns sequelae. our experience in the Department of Plastic and Reconstructive Surgery, Pristina, Kosovo.

Authors:  Z Buja; H Arifi; E Hoxha; S Duqi
Journal:  Ann Burns Fire Disasters       Date:  2015-09-30

Review 8.  Update on Keloid Management: Clinical and Basic Science Advances.

Authors:  Martha H Viera; Alejandra C Vivas; Brian Berman
Journal:  Adv Wound Care (New Rochelle)       Date:  2012-10       Impact factor: 4.730

9.  Long non-coding RNA H19 promotes the proliferation of fibroblasts in keloid scarring.

Authors:  Jie Zhang; Cai Yue Liu; Yun Wan; Li Peng; Wen Fang Li; Jia Xuan Qiu
Journal:  Oncol Lett       Date:  2016-08-02       Impact factor: 2.967

10.  Role of Hyaluronic Acid Treatment in the Prevention of Keloid Scarring.

Authors:  Andrea Hoffmann; Jessica Lynn Hoing; Mackenzie Newman; Richard Simman
Journal:  J Am Coll Clin Wound Spec       Date:  2013-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.